SIM
DARE icon

Spark Investment Management’s Dare Bioscience DARE Stock Holding History

Spark Investment Management’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-189
Closed -$203K – 677
2015
Q1 		$203K Buy
+189
New +$183K 0.03% 551

Other funds holding DARE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Spark Investment Management's DARE Position: Q2 2015 in Review

Spark Investment Management sold out of Dare Bioscience (DARE) in Q2 2015, closing a stake of 189 shares — an estimated $203K sold.

Spark Investment Management first reported a position in DARE in Q1 2015 and held it in 1 quarter. The position peaked at $203K in Q1 2015. 37 funds tracked by Wall St. Rank hold DARE as of Q2 2015.

  • Spark Investment Management reported no remaining Dare Bioscience position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 189 Dare Bioscience shares in Q2 2015, an estimated $203K.
  • Spark Investment Management first reported a position in Dare Bioscience in Q1 2015 and held it in 1 quarter.
  • Spark Investment Management's Dare Bioscience position peaked at $203K in Q1 2015.
  • 37 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.